Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis

Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis

Summary: Background: Global elimination of hepatitis B virus (HBV) requires expanded uptake of antiviral therapy, potentially by simplifying testing algorithms, especially in resource-limited countries. We evaluated the effectiveness, cost-effectiveness, and budget impact of three strategies that d...

Full description

Bibliographic Details
Main Authors: Liem B Luong Nguyen, PhD, Maud Lemoine, ProfPhD, Gibril Ndow, MD, Zachary J Ward, PhD, Timothy B Hallet, ProfPhD, Umberto D’Alessandro, ProfPhD, Mark Thursz, ProfMD, Shevanthi Nayagam, PhD, Yusuke Shimakawa, PhD
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:The Lancet Global Health
Online Access:http://www.sciencedirect.com/science/article/pii/S2214109X23004679

Internet

http://www.sciencedirect.com/science/article/pii/S2214109X23004679

Similar Items